Daily Business News
Monday, October 30, 2006
  Merck to buy Sirna for $1.1 billion in cash (Reuters)

A general view shows the Merck facility in Rahway New Jersey November 28 2005. Pharmaceutical company Merck  and  Co. Inc. on Monday said it agreed to acquire biotechnology firm Sirna Therapeutics Inc. for $1.1 billion in cash to bolster its research and development efforts in areas such as cancer treatments. (Jeff Zelevansky/Reuters)Reuters - Merck & Co. Inc. on Monday said it agreed to acquire biotechnology firm Sirna Therapeutics Inc. for $1.1 billion in cash to gain a stronger foothold in the promising drug-development technology of RNA interference.


 
Comments: Post a Comment



<< Home
RSS :
Add to Windows Live Add to My Yahoo! Subscribe with Bloglines Add to Google XML


LINKS
PREVIOUS
PARTNER LINKS
ARCHIVES
September 2006 / October 2006 / November 2006 / December 2006 /

Powered by Blogger